FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology
The United States Food and Drug Administration (FDA) has approved the start of multi-center Phase II clinical trials in the United States to treat amyotrophic lateral sclerosis (ALS) with adult…
